Om

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company focused on developing Alpha DaRT, a targeted alpha-radiation platform designed for the treatment of solid tumors. The company’s core work centers on research, clinical development, and commercialization of localized cancer therapies that deliver alpha particles directly inside tumor tissue while limiting exposure to surrounding healthy tissue. Alpha Tau Medical Ltd. is active in a range of oncology indications, including skin, oral, pancreatic, prostate, lung, liver, breast, and brain cancers, reflecting the broad potential use of its technology across difficult-to-treat solid tumors. Headquartered in Jerusalem, Israel, the company operates as a medical technology business serving the oncology sector and is centered on advancing precision radiation approaches for cancer care.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I ALPHA TAU MEDICAL MED ENDAVU: Køb Alpha Tau Medical ($H44) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Alpha Tau Medical, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.